Found 6 matching trials
A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria and Moderately Decreased GFR PHASE2 The purpose of this study is to evaluate pharmacodynamics, safety, tolerabi...
Show More Location
Investigational site
Learn More & Join Trial
An Extended Treatment Study of MT-3995 in Patients With Diabetic Nephropathy PHASE2 This study aims to evaluate the safety and efficacy of MT-3995 administered...
Show More Learn More & Join Trial
Efficacy and Safety of MT-3995 in Patients With Diabetic Nephropathy PHASE2 The purpose of this study is to evaluate the efficacy of MT-3995 in subject...
Show More Location
Investigational site
Learn More & Join Trial
Safety, Tolerability and Pharmacokinetic Study of MT-3995 at a Low Dose in Subjects With Diabetic Nephropathy PHASE1 The purpose of this study is to evaluate safety, tolerability and pharmacok...
Show More Learn More & Join Trial
A Study to Evaluate Pharmacodynamics, Safety, Tolerability and Pharmacokinetics of MT-3995 in Type II Diabetic Nephropathy Subjects With Albuminuria PHASE2 The purpose of this study is to evaluate pharmacodynamics, safety, tolerabi...
Show More Location
Investigational site
Learn More & Join Trial
Safety, Tolerability and Pharmacokinetic Study of MT-3995 in Subjects With Diabetic Nephropathy PHASE1 The purpose of this study is to evaluate safety, tolerability and pharmacok...
Show More Learn More & Join Trial